| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 1.26e-05 | 9 | 108 | 3 | GO:0016308 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 2.46e-05 | 11 | 108 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 4.23e-05 | 13 | 108 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 7.02e-05 | 41 | 108 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 7.73e-05 | 42 | 108 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.28e-04 | 143 | 108 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 1.73e-04 | 4 | 108 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | clathrin adaptor activity | 2.20e-04 | 22 | 108 | 3 | GO:0035615 | |
| GeneOntologyMolecularFunction | cargo adaptor activity | 3.25e-04 | 25 | 108 | 3 | GO:0140312 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 3.65e-04 | 26 | 108 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 6.81e-04 | 32 | 108 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 1.27e-03 | 10 | 108 | 2 | GO:0016176 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ELOB ZSWIM8 ANK3 GON4L SHANK3 RETREG3 KMT2D SHANK2 AP2A1 SNAP91 MDC1 SYNE2 ARID5B EPN1 MAPK8IP2 | 1.44e-03 | 1160 | 108 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.85e-03 | 12 | 108 | 2 | GO:0016175 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.77e-05 | 12 | 107 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | postsynaptic density | DLGAP1 ANK3 PCLO CRTC1 PIP5K1C SHANK3 SHANK2 SNAP91 MACF1 MAPK8IP2 | 1.08e-04 | 451 | 107 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 1.62e-04 | 21 | 107 | 3 | GO:0030132 | |
| GeneOntologyCellularComponent | asymmetric synapse | DLGAP1 ANK3 PCLO CRTC1 PIP5K1C SHANK3 SHANK2 SNAP91 MACF1 MAPK8IP2 | 1.70e-04 | 477 | 107 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | clathrin coat | 1.94e-04 | 56 | 107 | 4 | GO:0030118 | |
| GeneOntologyCellularComponent | postsynaptic specialization | DLGAP1 ANK3 PCLO CRTC1 PIP5K1C SHANK3 SHANK2 SNAP91 MACF1 MAPK8IP2 | 2.60e-04 | 503 | 107 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | DLGAP1 ANK3 PCLO CRTC1 PIP5K1C SHANK3 SHANK2 SNAP91 MACF1 MAPK8IP2 | 3.54e-04 | 523 | 107 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | clathrin-coated pit | 7.61e-04 | 80 | 107 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 9.66e-04 | 38 | 107 | 3 | GO:0030125 | |
| Domain | PDZ | 1.70e-04 | 151 | 101 | 6 | PS50106 | |
| Domain | PDZ | 1.77e-04 | 152 | 101 | 6 | IPR001478 | |
| Domain | HECT | 4.09e-04 | 27 | 101 | 3 | PF00632 | |
| Domain | HECTc | 4.09e-04 | 27 | 101 | 3 | SM00119 | |
| Domain | HECT_dom | 4.09e-04 | 27 | 101 | 3 | IPR000569 | |
| Domain | HECT | 4.09e-04 | 27 | 101 | 3 | PS50237 | |
| Domain | PInositol-4-P-5-kinase | 5.97e-04 | 7 | 101 | 2 | IPR023610 | |
| Domain | PIPKc | 7.94e-04 | 8 | 101 | 2 | SM00330 | |
| Domain | - | 7.94e-04 | 8 | 101 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 7.94e-04 | 8 | 101 | 2 | PF01504 | |
| Domain | PIPK | 7.94e-04 | 8 | 101 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 7.94e-04 | 8 | 101 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 7.94e-04 | 8 | 101 | 2 | IPR027483 | |
| Domain | - | 7.94e-04 | 8 | 101 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 7.94e-04 | 8 | 101 | 2 | IPR002498 | |
| Domain | ENTH | 1.02e-03 | 9 | 101 | 2 | PS50942 | |
| Domain | zf-C2H2_11 | 1.02e-03 | 9 | 101 | 2 | PF16622 | |
| Domain | ENTH | 1.02e-03 | 9 | 101 | 2 | SM00273 | |
| Domain | PDZ | 1.26e-03 | 148 | 101 | 5 | SM00228 | |
| Domain | ENTH | 1.27e-03 | 10 | 101 | 2 | IPR013809 | |
| Domain | - | 1.33e-03 | 150 | 101 | 5 | 2.30.42.10 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX3 LMTK2 LAMC3 MLXIP KDM6B PIP5K1C MAP3K5 HIVEP3 EPS15L1 KMT2D SHANK2 AP2A1 ZFP36L2 ZNF592 NBEAL2 NAV1 HERC1 PRRC2B AHNAK2 | 1.59e-09 | 1105 | 109 | 19 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAPH1 WEE1 RBBP6 FNBP4 PAGR1 TRIP12 ZNF768 EPS15L1 KMT2D PTPRC ZNF592 MDC1 PKN2 ZMYM3 TOP2B CDC23 | 2.71e-09 | 774 | 109 | 16 | 15302935 |
| Pubmed | ANK3 RBBP6 FNBP4 TRIP12 VSIR CUEDC1 KMT2D PTPN12 PTPRC AP2A1 ZNF592 MACF1 HERC1 EPN1 | 5.25e-09 | 591 | 109 | 14 | 15231748 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANK3 RAPH1 FXR2 RBBP6 CRTC1 TRIP12 ZNF592 MDC1 MACF1 PRRC2B CPSF7 | 2.01e-08 | 361 | 109 | 11 | 26167880 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.13e-08 | 281 | 109 | 10 | 28706196 | |
| Pubmed | DLGAP1 ANK3 FXR2 SHANK3 MAP3K5 EPS15L1 SHANK2 AP2A1 ZKSCAN1 SNAP91 WASF2 SYNE2 NAV1 MACF1 MAPK8IP2 PRRC2B | 5.68e-08 | 963 | 109 | 16 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPH1 WEE1 LMTK2 CRTC1 MLXIP DPP8 TRIP12 ZFP36L2 STARD9 SYNE2 NAV1 MACF1 GNAS AHNAK2 DOP1B | 8.34e-08 | 861 | 109 | 15 | 36931259 |
| Pubmed | Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. | 2.98e-07 | 5 | 109 | 3 | 9723620 | |
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 16413285 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 15123724 | ||
| Pubmed | GON4L MLXIP PIP5K1C STARD9 NAV1 MACF1 TET3 ZMYM3 PRRC2B DOP1B | 6.57e-07 | 407 | 109 | 10 | 12693553 | |
| Pubmed | 9.21e-07 | 103 | 109 | 6 | 32744500 | ||
| Pubmed | ELOB PCNX3 RBBP6 ARHGAP10 GON4L CRTC1 ZNF768 CUEDC1 GORASP2 SHANK2 ZKSCAN1 ZFP36L2 ZNF592 WASF2 MDC1 MACF1 EPN1 ZMYM3 | 9.37e-07 | 1497 | 109 | 18 | 31527615 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 10527873 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.33e-06 | 440 | 109 | 10 | 34244565 | |
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 2.04e-06 | 29 | 109 | 4 | 19208628 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 WEE1 RBBP6 ARID5B NAV1 MACF1 GNAS ZMYM3 PRRC2B CDC23 CPSF7 | 2.53e-06 | 588 | 109 | 11 | 38580884 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ELOB RBBP6 FNBP4 PAGR1 MLXIP TRIP12 ZNF768 KMT2D AP2A1 MDC1 ARID5B TET3 ZMYM3 TOP2B CDC23 CPSF7 | 2.83e-06 | 1294 | 109 | 16 | 30804502 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 3.09e-06 | 377 | 109 | 9 | 38117590 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ZSWIM8 RAPH1 WEE1 CRTC1 PAGR1 MLXIP EPS15L1 GORASP2 SHANK2 AP2A1 ZFP36L2 GNAS EPN1 CDC23 | 4.70e-06 | 1038 | 109 | 14 | 26673895 |
| Pubmed | DLGAP1 ARHGAP23 FXR2 SHANK3 SNAP91 STARD9 ACAN MACF1 MAPK8IP2 | 8.90e-06 | 430 | 109 | 9 | 32581705 | |
| Pubmed | 9.33e-06 | 549 | 109 | 10 | 38280479 | ||
| Pubmed | 9.50e-06 | 234 | 109 | 7 | 36243803 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 10506216 | ||
| Pubmed | Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice. | 9.73e-06 | 2 | 109 | 2 | 31226719 | |
| Pubmed | PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. | 9.73e-06 | 2 | 109 | 2 | 18073347 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12682053 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33126897 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26204806 | ||
| Pubmed | Synapse structure: glutamate receptors connected by the shanks. | 9.73e-06 | 2 | 109 | 2 | 10574750 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 32376619 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23225497 | ||
| Pubmed | TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitment. | 9.73e-06 | 2 | 109 | 2 | 32405722 | |
| Pubmed | Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. | 9.73e-06 | 2 | 109 | 2 | 19153220 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26086043 | ||
| Pubmed | Expression profiles of the autism-related SHANK proteins in the human brain. | 9.73e-06 | 2 | 109 | 2 | 37953224 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 36100669 | ||
| Pubmed | Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner. | 9.73e-06 | 2 | 109 | 2 | 23300084 | |
| Pubmed | Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. | 9.73e-06 | 2 | 109 | 2 | 22699619 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20800661 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31052177 | ||
| Pubmed | PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. | 9.73e-06 | 2 | 109 | 2 | 19889969 | |
| Pubmed | Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in the Mouse Hippocampus. | 9.73e-06 | 2 | 109 | 2 | 27199660 | |
| Pubmed | SHANK3 in vagal sensory neurons regulates body temperature, systemic inflammation, and sepsis. | 9.73e-06 | 2 | 109 | 2 | 36845137 | |
| Pubmed | RBBP6 BCL7B GON4L PAGR1 ZNF768 KMT2D ZKSCAN1 ZNF592 DGKK MDC1 SYNE2 ARID5B HERC1 ZMYM3 PRRC2B CPSF7 | 9.87e-06 | 1429 | 109 | 16 | 35140242 | |
| Pubmed | Redundant and nonredundant organismal functions of EPS15 and EPS15L1. | 1.06e-05 | 14 | 109 | 3 | 30692166 | |
| Pubmed | 1.06e-05 | 14 | 109 | 3 | 21795692 | ||
| Pubmed | ZSWIM8 ARHGAP23 FXR2 WEE1 RBBP6 ARHGAP10 BCL7B ZNF768 ZNF592 MACF1 VPS53 ZMYM3 PRRC2B CDC23 | 1.07e-05 | 1116 | 109 | 14 | 31753913 | |
| Pubmed | ZSWIM8 DLGAP1 ANK3 MAGEH1 KDM6B TRIP12 CUEDC1 EPS15L1 GORASP2 AP2A1 ZNF592 ARID5B MACF1 MAPK8IP2 DOP1B | 1.18e-05 | 1285 | 109 | 15 | 35914814 | |
| Pubmed | 1.43e-05 | 347 | 109 | 8 | 17114649 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ELOB ANK3 WEE1 ARHGAP10 CRTC1 DPP8 EPS15L1 GORASP2 AP2A1 ZFP36L2 PTPRQ NAV1 VPS53 PRRC2B CDC23 | 1.63e-05 | 1321 | 109 | 15 | 27173435 |
| Pubmed | 2.28e-05 | 268 | 109 | 7 | 33640491 | ||
| Pubmed | 2.36e-05 | 18 | 109 | 3 | 10567358 | ||
| Pubmed | 2.74e-05 | 496 | 109 | 9 | 31343991 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 2.91e-05 | 3 | 109 | 2 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 2.91e-05 | 3 | 109 | 2 | 27044504 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 2.91e-05 | 3 | 109 | 2 | 24358335 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10891396 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 2.91e-05 | 3 | 109 | 2 | 18787174 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 26209274 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 24873968 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 2.91e-05 | 3 | 109 | 2 | 11018074 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 2.91e-05 | 3 | 109 | 2 | 33545139 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10806096 | ||
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 2.91e-05 | 3 | 109 | 2 | 20142487 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9116268 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 2.91e-05 | 3 | 109 | 2 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 2.91e-05 | 3 | 109 | 2 | 25565313 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 39357591 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12958309 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 11435342 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 31118934 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23482812 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16041040 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10085000 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10987289 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 2.91e-05 | 3 | 109 | 2 | 18703411 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 29228045 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 17307863 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 2.91e-05 | 3 | 109 | 2 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 2.91e-05 | 3 | 109 | 2 | 24576409 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22376231 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 2.91e-05 | 3 | 109 | 2 | 28274989 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 2.91e-05 | 3 | 109 | 2 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 2.91e-05 | 3 | 109 | 2 | 24549323 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 34557202 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 28467721 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 2.91e-05 | 3 | 109 | 2 | 20881184 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 14681219 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 26528554 | ||
| Interaction | TOP3B interactions | PCNX3 FXR2 LMTK2 LAMC3 MLXIP KDM6B PIP5K1C MAP3K5 HIVEP3 EPS15L1 GORASP2 KMT2D SHANK2 AP2A1 ZFP36L2 ZNF592 NBEAL2 MDC1 NAV1 GNAS HERC1 ADAMTSL4 PRRC2B AHNAK2 | 4.90e-07 | 1470 | 106 | 24 | int:TOP3B |
| Interaction | AGAP2 interactions | 1.67e-06 | 210 | 106 | 9 | int:AGAP2 | |
| Interaction | YWHAG interactions | DLGAP1 RAPH1 ARHGAP23 WEE1 SH2D3A LMTK2 CRTC1 MLXIP TRIP12 SHANK3 MAP3K5 ZFP36L2 STARD9 WASF2 SYNE2 NAV1 MACF1 PKN2 GNAS ZMYM3 AHNAK2 | 1.81e-06 | 1248 | 106 | 21 | int:YWHAG |
| Interaction | RAPGEF5 interactions | 1.59e-05 | 60 | 106 | 5 | int:RAPGEF5 | |
| Interaction | YWHAH interactions | DLGAP1 FXR2 WEE1 LMTK2 CRTC1 MLXIP DPP8 TRIP12 MAP3K5 ZFP36L2 STARD9 WASF2 SYNE2 NAV1 MACF1 HERC1 AHNAK2 DOP1B | 1.66e-05 | 1102 | 106 | 18 | int:YWHAH |
| Interaction | ARHGAP12 interactions | 2.93e-05 | 68 | 106 | 5 | int:ARHGAP12 | |
| Interaction | TNIK interactions | DLGAP1 ANK3 FXR2 SHANK3 SHANK2 AP2A1 SNAP91 SYNE2 MACF1 PRRC2B | 3.30e-05 | 381 | 106 | 10 | int:TNIK |
| Interaction | AMPH interactions | 3.87e-05 | 72 | 106 | 5 | int:AMPH | |
| Interaction | UBXN6 interactions | 5.50e-05 | 325 | 106 | 9 | int:UBXN6 | |
| Interaction | NRXN1 interactions | 5.67e-05 | 127 | 106 | 6 | int:NRXN1 | |
| Interaction | NECAP1 interactions | 5.70e-05 | 78 | 106 | 5 | int:NECAP1 | |
| Interaction | NCK2 interactions | 7.37e-05 | 262 | 106 | 8 | int:NCK2 | |
| Interaction | YWHAB interactions | DLGAP1 ARHGAP23 WEE1 SH2D3A CRTC1 MLXIP DPP8 TRIP12 SHANK3 MAP3K5 ZFP36L2 STARD9 WASF2 NAV1 MACF1 AHNAK2 | 7.78e-05 | 1014 | 106 | 16 | int:YWHAB |
| Interaction | CECR2 interactions | 9.95e-05 | 46 | 106 | 4 | int:CECR2 | |
| Interaction | NEDD4 interactions | ANK3 WEE1 KDM6B PIP5K1C SHANK3 MAP3K5 CUEDC1 YOD1 ZFP36L2 PIP5K1A PKN2 | 1.38e-04 | 544 | 106 | 11 | int:NEDD4 |
| Interaction | RAPGEF4 interactions | 1.38e-04 | 50 | 106 | 4 | int:RAPGEF4 | |
| Cytoband | 7q11.23 | 8.79e-05 | 97 | 109 | 4 | 7q11.23 | |
| GeneFamily | PDZ domain containing | 2.69e-05 | 152 | 70 | 6 | 1220 | |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.52e-06 | 195 | 108 | 8 | M5334 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.70e-06 | 198 | 108 | 8 | M7948 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ANK3 RAPH1 ARHGAP23 PCLO SHANK3 HIVEP3 AMER2 SHANK2 SNAP91 ANKIB1 NAV1 HERC1 VPS53 MAPK8IP2 PRRC2B AHNAK2 DOP1B | 2.77e-06 | 1106 | 108 | 17 | M39071 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.73e-05 | 196 | 108 | 7 | M5381 | |
| Coexpression | GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 1.97e-05 | 200 | 108 | 7 | M5859 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 3.11e-05 | 295 | 108 | 8 | M39121 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | RBBP6 MAP3K5 EPS15L1 PTPRC ZFP36L2 SYNE2 ARID5B MACF1 TET3 TOP2B | 4.11e-05 | 498 | 108 | 10 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | RBBP6 MAP3K5 EPS15L1 PTPRC ZFP36L2 SYNE2 ARID5B MACF1 TET3 TOP2B | 4.78e-05 | 507 | 108 | 10 | MM1030 |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 5.58e-05 | 161 | 108 | 6 | M11857 | |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 5.78e-05 | 162 | 108 | 6 | M8243 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP | 7.31e-05 | 169 | 108 | 6 | M40877 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 8.09e-05 | 338 | 108 | 8 | M17094 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | GALNT10 MXRA5 GON4L PAGR1 MLXIP RETREG3 MAP3K5 SHANK2 ZFP36L2 SYNE2 GNAS HERC1 | 1.25e-04 | 807 | 108 | 12 | M16651 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 1.35e-04 | 189 | 108 | 6 | M9978 | |
| Coexpression | GAVIN_PDE3B_TARGETS | 1.46e-04 | 25 | 108 | 3 | MM726 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.79e-04 | 199 | 108 | 6 | M9443 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 1.79e-04 | 199 | 108 | 6 | M3257 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 1.79e-04 | 199 | 108 | 6 | M4460 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.84e-04 | 200 | 108 | 6 | M5063 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 1.84e-04 | 200 | 108 | 6 | M9439 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 1.84e-04 | 200 | 108 | 6 | M9354 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 1.84e-04 | 200 | 108 | 6 | M5851 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 1.84e-04 | 200 | 108 | 6 | M5870 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 1.84e-04 | 200 | 108 | 6 | M5261 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 1.84e-04 | 200 | 108 | 6 | M9923 | |
| Coexpression | GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M3047 | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.86e-07 | 198 | 109 | 7 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-07 | 198 | 109 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.27e-07 | 200 | 109 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.04e-06 | 171 | 109 | 6 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.40e-06 | 190 | 109 | 6 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | (1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.62e-06 | 191 | 109 | 6 | 66ddff9a99092cb384b9fb2a3ba95ddbebed67cc | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.09e-06 | 193 | 109 | 6 | 7deb439943d35a4e825674b2b7dcddb45d366ad1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-06 | 194 | 109 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.33e-06 | 194 | 109 | 6 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 195 | 109 | 6 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.09e-06 | 197 | 109 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.09e-06 | 197 | 109 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 9.36e-06 | 198 | 109 | 6 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 9.36e-06 | 198 | 109 | 6 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.63e-06 | 199 | 109 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.63e-06 | 199 | 109 | 6 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 109 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.28e-05 | 138 | 109 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-05 | 152 | 109 | 5 | aa88084ba1851d879ece82baa516f6b46cbd2eb8 | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 3.74e-05 | 153 | 109 | 5 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.11e-05 | 156 | 109 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.91e-05 | 162 | 109 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 171 | 109 | 5 | 58bdcbc65062ac09f1c014e08302f938a3e6b252 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.35e-05 | 171 | 109 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-05 | 177 | 109 | 5 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 177 | 109 | 5 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-05 | 177 | 109 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.88e-05 | 179 | 109 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.09e-05 | 180 | 109 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 8.30e-05 | 181 | 109 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19_Severe-PLT_1|COVID-19_Severe / Disease Group and Platelet Clusters | 8.30e-05 | 181 | 109 | 5 | 20f7603ceb89b965570e39ae3e88a6d26ebf5b67 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 182 | 109 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.75e-05 | 183 | 109 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.20e-05 | 185 | 109 | 5 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.20e-05 | 185 | 109 | 5 | 74b787e225d83efcb84e79c23499febe1a106622 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 185 | 109 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.20e-05 | 185 | 109 | 5 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.20e-05 | 185 | 109 | 5 | 48de4d9fad55077732bf64eca4919103ecbc1512 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.20e-05 | 185 | 109 | 5 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 186 | 109 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 186 | 109 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.68e-05 | 187 | 109 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.68e-05 | 187 | 109 | 5 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.68e-05 | 187 | 109 | 5 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 188 | 109 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 188 | 109 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 9.93e-05 | 188 | 109 | 5 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.93e-05 | 188 | 109 | 5 | 53213d0c907ce4522fc00699cb38fa78ed0bef7e | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.02e-04 | 189 | 109 | 5 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 190 | 109 | 5 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-04 | 190 | 109 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 190 | 109 | 5 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_fh|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.04e-04 | 190 | 109 | 5 | 120ca702600373c208a3d032fede0a040736e5cf | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-04 | 190 | 109 | 5 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 191 | 109 | 5 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.10e-04 | 192 | 109 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 192 | 109 | 5 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.10e-04 | 192 | 109 | 5 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 192 | 109 | 5 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 192 | 109 | 5 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 192 | 109 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 193 | 109 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 193 | 109 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 193 | 109 | 5 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.12e-04 | 193 | 109 | 5 | 498d3a83bce6deff69aea71b18a43688e0a8ed7d | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-04 | 194 | 109 | 5 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | myeloid-CD16+_Monocyte|myeloid / Lineage and Cell class | 1.15e-04 | 194 | 109 | 5 | aeeadfeb01827dbc7de6576c76fb2e41a3c59247 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 1.18e-04 | 195 | 109 | 5 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 195 | 109 | 5 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 1.21e-04 | 196 | 109 | 5 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 196 | 109 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-04 | 196 | 109 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.21e-04 | 196 | 109 | 5 | 7aa6778b78a8549dd4d0a5278ef8017334b00c38 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-04 | 196 | 109 | 5 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 197 | 109 | 5 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 197 | 109 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.24e-04 | 197 | 109 | 5 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|normal_Lung / Location, Cell class and cell subclass | 1.24e-04 | 197 | 109 | 5 | 559b22ff973a1551e614a972085343e7d8e8a668 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.24e-04 | 197 | 109 | 5 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_1|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.27e-04 | 198 | 109 | 5 | bc6b983fdb9547ef8a9e693bc15fced1b73e101f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 198 | 109 | 5 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 198 | 109 | 5 | fc8099bce80d84b29bdcc87064d4d8375dddfa0f | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-04 | 198 | 109 | 5 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 198 | 109 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-04 | 198 | 109 | 5 | 32ec322ed144c545014b191da5274d12feeaf96b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-04 | 198 | 109 | 5 | 1e281d8f0291e8cf814e9e5abd7f5860402a7c77 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 198 | 109 | 5 | 72c7474e084d1334a09c0a3b0f3c3137038794c8 | |
| Drug | benz(a)anthracene | ANK3 RAPH1 ARHGAP23 WEE1 RBBP6 PCLO MAGEH1 BCL7B FNBP4 GON4L CCDC81 ZC3H6 VSIR IER3 SYNE2 HERC1 ZMYM3 AHNAK2 | 2.03e-05 | 1251 | 107 | 18 | ctd:C030935 |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A | 3.60e-05 | 193 | 107 | 7 | 4503_UP | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HG-U133A | 3.97e-05 | 196 | 107 | 7 | 1929_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 4355_DN | |
| Drug | tamoxifen citrate; Down 200; 1uM; ssMCF7; HG-U133A | 4.10e-05 | 197 | 107 | 7 | 375_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 4553_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 2730_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; PC3; HG-U133A | 4.23e-05 | 198 | 107 | 7 | 1918_UP | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | 4.23e-05 | 198 | 107 | 7 | 169_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 7174_DN | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 5326_UP | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 2514_UP | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 4637_DN | |
| Disease | Manic | 1.07e-05 | 78 | 109 | 5 | C0338831 | |
| Disease | estradiol measurement | 5.64e-05 | 110 | 109 | 5 | EFO_0004697 | |
| Disease | cancer (implicated_via_orthology) | 6.38e-05 | 268 | 109 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.34e-04 | 5 | 109 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | Manic Disorder | 1.41e-04 | 71 | 109 | 4 | C0024713 | |
| Disease | language measurement | 1.43e-04 | 134 | 109 | 5 | EFO_0007797 | |
| Disease | Mental Retardation, Psychosocial | 1.70e-04 | 139 | 109 | 5 | C0025363 | |
| Disease | Profound Mental Retardation | 1.70e-04 | 139 | 109 | 5 | C0020796 | |
| Disease | Mental deficiency | 1.70e-04 | 139 | 109 | 5 | C0917816 | |
| Disease | bipolar I disorder | 1.82e-04 | 141 | 109 | 5 | EFO_0009963 | |
| Disease | glucagon measurement, glucose tolerance test | 2.01e-04 | 6 | 109 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Depression, Bipolar | 2.14e-04 | 79 | 109 | 4 | C0005587 | |
| Disease | Intellectual Disability | 2.61e-04 | 447 | 109 | 8 | C3714756 | |
| Disease | Autism Spectrum Disorders | 2.83e-04 | 85 | 109 | 4 | C1510586 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 4.31e-04 | 170 | 109 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | urate measurement | PCNX3 LMTK2 GON4L CCDC81 MLXIP TP53INP2 SHANK2 NAV1 GNAS HERC6 PRRC2B | 4.84e-04 | 895 | 109 | 11 | EFO_0004531 |
| Disease | serum gamma-glutamyl transferase measurement | AMH PCNX3 ARHGAP10 BCL7B LMTK2 GON4L MAP3K7CL ZNF768 SLC24A4 NBEAL2 PKN2 | 5.76e-04 | 914 | 109 | 11 | EFO_0004532 |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 7.28e-04 | 11 | 109 | 2 | EFO_0009923 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 8.71e-04 | 12 | 109 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | bipolar disorder | 1.38e-03 | 577 | 109 | 8 | MONDO_0004985 | |
| Disease | total blood protein measurement | 1.42e-03 | 449 | 109 | 7 | EFO_0004536 | |
| Disease | Schizoaffective disorder-bipolar type | 1.57e-03 | 16 | 109 | 2 | EFO_0009965 | |
| Disease | Pontoneocerebellar hypoplasia | 1.57e-03 | 16 | 109 | 2 | cv:C1261175 | |
| Disease | cutaneous melanoma, hair color | 1.58e-03 | 62 | 109 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | breast carcinoma (is_marker_for) | 1.89e-03 | 66 | 109 | 3 | DOID:3459 (is_marker_for) | |
| Disease | uric acid measurement | 1.95e-03 | 610 | 109 | 8 | EFO_0004761 | |
| Disease | basophil count, eosinophil count | 2.04e-03 | 241 | 109 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | body fat percentage | 2.27e-03 | 488 | 109 | 7 | EFO_0007800 | |
| Disease | body weight | GALNTL6 GON4L CRTC1 OTOL1 MAP3K7CL KCNB2 TRIP12 TP53INP2 SLC24A4 ACAN DGKK GNAS | 2.43e-03 | 1261 | 109 | 12 | EFO_0004338 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.48e-03 | 152 | 109 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.63e-03 | 74 | 109 | 3 | DOID:3748 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 2.72e-03 | 156 | 109 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | eosinophilic esophagitis | 3.18e-03 | 163 | 109 | 4 | EFO_0004232 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPDPFQTEDPFKSDP | 616 | Q9UBC2 | |
| PDPASVDPPSDPSAD | 346 | Q8N7J2 | |
| EIPPAPEESFTTIPD | 216 | Q96KC9 | |
| ETPTTEVPAPFFLPA | 561 | Q9UJX2 | |
| EEAIPSPTPRAEPFS | 191 | Q6UY14 | |
| DPTPNDCFEPVSPEF | 461 | Q8IUA7 | |
| EAFLSELEPPAPESP | 701 | O95782 | |
| NPPDPDEPSESTLDI | 786 | Q9P2G1 | |
| DFDTDFDPSILPPPD | 756 | O14490 | |
| SEAQISDPFAPEPTP | 396 | O60641 | |
| PLVSDDDVFPLSPPD | 536 | Q05D60 | |
| DDVFPLSPPDMSFPA | 541 | Q05D60 | |
| EPSLPSSEVADEPPT | 146 | Q9BQE9 | |
| PTVPEDLFFLEEGPS | 756 | Q8IWY9 | |
| PVEADFLSPFSVPEA | 406 | Q8NFF2 | |
| VVEFPSPPSDSDFPP | 1061 | Q70E73 | |
| FSLDSEDPSPASPPL | 226 | Q9BTK6 | |
| GPPPSTVSEAEFEDI | 326 | Q8N684 | |
| DPFPQESPLDTFPEP | 401 | O60393 | |
| PDPDTPPLTIFSSND | 276 | Q5VVQ6 | |
| LSDETLPAPEFSPEP | 301 | P04217 | |
| VEEFPFDSEGPTEPT | 331 | Q9NPB9 | |
| EKIFRTPPDTTFPEP | 571 | A1A4S6 | |
| ATEPASEPAPEPATE | 86 | Q5KSL6 | |
| SGPEIFTFDPLPEPA | 31 | P46695 | |
| KPVEPAASDLEPFTP | 1651 | Q14676 | |
| PEEDPSTPEEASTTP | 51 | Q9H213 | |
| PSEFLPSFPLVPESS | 361 | Q9H8Y8 | |
| LLDTSEPEPPVDSEP | 521 | P51116 | |
| PELQKADPSDPFESP | 301 | Q86SR1 | |
| TPGPDSPIFLPTDSE | 371 | Q9BYJ1 | |
| PADSPGTPFLDFPVT | 2261 | Q9Y3R5 | |
| FPESFTVPDLEPVPE | 3946 | Q15751 | |
| FDFPPTPLEDQFEEP | 671 | O15054 | |
| SIEEASSPASEPEPP | 296 | Q13387 | |
| RLPTEPPSPVAEFSE | 211 | Q9HCN6 | |
| PSIESDPEGFEISPE | 1861 | Q9Y6V0 | |
| DTDPPSEAELPASPD | 336 | Q9H6A9 | |
| PFLPSDPEPPETSEE | 21 | A0A1W2PR82 | |
| RTLEPDSSDEEPPPV | 116 | Q9NWM3 | |
| PAETPSPVIFSDFPF | 611 | Q8IVU3 | |
| EEPTSPAAAVPTPEE | 1011 | O94854 | |
| EEPTSPAAAVPTPEE | 1076 | O94854 | |
| ASPAAAVPTPEEPAF | 1131 | O94854 | |
| PFPASEPSLETPDSL | 986 | Q8IWU2 | |
| PSAELEESPPSADPF | 276 | P03971 | |
| PSDPSEFGTEFRAPP | 76 | Q12950 | |
| EISEGSPIPDPSFSP | 521 | Q99755 | |
| IPASFLEPLDSPDET | 206 | A6NI72 | |
| IPASFLEPLDSPDET | 181 | A8MVU1 | |
| EVSPSPLEPEEPFTF | 406 | P16112 | |
| EPSPSEVPFPSEEPS | 786 | P16112 | |
| EVPFPSEEPSPSEEP | 791 | P16112 | |
| SEEPSPSEEPFPSVR | 796 | P16112 | |
| ELFPSEEPFPSKEPS | 816 | P16112 | |
| EEPFPSKEPSPSEEP | 821 | P16112 | |
| PSEEPSASEEPYTPS | 831 | P16112 | |
| PPFLPEEPSSSSEED | 236 | Q7Z6E9 | |
| EGSPTPDPSFSPLVE | 471 | A2A3N6 | |
| PISILTEEDAPDSPP | 886 | Q9UMZ3 | |
| EDPFIQPTDFGPSEP | 406 | Q9HAP2 | |
| TDFTETERSPLPPPS | 611 | Q92953 | |
| EALCIEPFSSPPELP | 86 | Q15370 | |
| SRLPPFEPDSSEPIF | 496 | Q6ZN84 | |
| PLDPEEPTFPALSSS | 261 | Q6UUV9 | |
| PLPDYTPPEIFSFES | 626 | Q6V1X1 | |
| PPTFASPETAPEVET | 1556 | Q3T8J9 | |
| ESTPTSEPNPFPFHE | 3591 | Q12955 | |
| DFSPPEVPEPTFLEN | 6 | Q9NQG1 | |
| ADVFTAPAPAPTTDP | 261 | Q9Y6I3 | |
| PEDFPEPSPASSPSE | 91 | Q9BXA9 | |
| PSSGPPPEEEETLFT | 46 | A6NHN0 | |
| PDENFEDHSAPPSPE | 1021 | Q99683 | |
| TPPEDSIPLVFPELD | 26 | P57077 | |
| PESDDQSELPSPPAL | 971 | Q8NEY1 | |
| DHINFPVFEPSTPDP | 646 | Q8ND04 | |
| PELQRADPSDPFESP | 296 | Q49A17 | |
| DFPSPSVPLKASDPE | 156 | Q8IYJ3 | |
| SDVDIFPSDFPTEPP | 1581 | Q02880 | |
| PLPSFDEVDSGDQPP | 6776 | Q8WXH0 | |
| PEPEPDTEPDSTAAV | 31 | Q8N3X1 | |
| PDLLPCTPPSFEEAT | 506 | O60331 | |
| YTTPEDATPEPGEDP | 961 | Q5JWF2 | |
| PTESPAEPSDVFLPS | 1321 | Q6ZNJ1 | |
| AEPSDVFLPSEAPCP | 1326 | Q6ZNJ1 | |
| EDSPPPLPERTPESF | 671 | Q05209 | |
| EPFPGSADEIPTETF | 1221 | Q9P2P6 | |
| FDDEFTSEAPILTPP | 946 | Q16513 | |
| ADTPIEEFTPTPAFP | 646 | Q9UPX8 | |
| FPAPSSEDDVFIPTV | 5396 | Q8IVF2 | |
| PESEPQEASFPSFPT | 586 | Q14865 | |
| IPNAVDPTDFTPDPF | 206 | P37287 | |
| DPEESFARDLPDFPS | 321 | Q86VR2 | |
| EDSAFQEPDSPLPPA | 51 | P30291 | |
| TPPEHFPFSDPEDDF | 401 | P61129 | |
| SSLFFSTPSPPEDPD | 6 | Q8IXH6 | |
| AETPIEEFTPTPAFP | 591 | Q9BYB0 | |
| SVTPTAPPEDEDPAL | 391 | A6NFA1 | |
| TPSFELPDASERPPT | 216 | Q9BRG2 | |
| LAQSPASFPPEASEP | 451 | Q9P227 | |
| PGDVFFPSLDPVPDS | 291 | Q9H7M9 | |
| FPSLDPVPDSPNFEV | 296 | Q9H7M9 | |
| FSPISSPEPEDPIKD | 141 | Q92610 | |
| PPQDHFLTDPAFSEP | 636 | Q9BXP2 | |
| EFEPQSPRFEPESPG | 71 | Q9H5H4 | |
| PSPEFAPRSPESDSQ | 96 | Q9H5H4 | |
| TAQSLEDPPPFVEPS | 331 | Q5T1R4 | |
| PEFPAQETPTTFPEE | 576 | Q5JSZ5 | |
| PPEPSYDPFTDSEER | 2526 | Q8WWQ8 | |
| SSAFPPATPRTEFPE | 421 | O43151 | |
| ESPPPSTNPFLEDEP | 376 | Q5VIR6 | |
| SFSEDNLPPPPAEFS | 261 | Q9Y6W5 | |
| PSTFLPEPPDTYEED | 656 | A7E2V4 | |
| DSTLQDTPPPDPEIF | 41 | P17029 | |
| PTPPENITFEDPSLD | 1456 | Q14669 | |
| PVFDAPPSPPDSLSD | 441 | P47974 | |
| DPPSEPSPLEAEFQR | 936 | P08575 | |
| MDPSDFPSPFDPLTL | 1 | Q14202 | |
| EASPLSPPFEESPLS | 541 | O14686 | |
| ETSEDVAPPLPPFHF | 611 | Q9Y6N6 | |
| SSPEPTSSEYEPPLD | 951 | Q9NR99 |